The global caryophyllene market is projected to reach US$ 889.06 million by 2034 from US$ 486.39 million in 2025, registering a CAGR of 6.93% during 2026 to 2034, and the Caryophyllene Market Forecast is supported by the structural certainty of ongoing pharmaceutical research investment in beta-caryophyllene's CB2 receptor bioactivity, the institutionalized clean-label requirements in European...